Surrogate viruses for use in disinfectant efficacy tests to justify claims against Monkeypox

7 July 2022

For sponsors and manufacturers wishing to make label claims of efficacy against Monkeypox for products that are either hard surface disinfectants or disinfectants that are medical devices, the following surrogate viruses can be used in testing to substantiate such a claim:

• Vaccinia virus

At this point, no other surrogate viruses have been identified.

If viruses other than the specified surrogates are to be used, contact [email protected](link sends e-mail)